Compare GSK plc (GSK) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs State Street PDR S&P Retail ETF — how do they compare? GSK plc trades at $52.72 (market cap $101.34B), while State Street PDR S&P Retail ETF trades at $90.94. The key difference: GSK plc pays a 3.49% dividend while State Street PDR S&P Retail ETF pays none, and State Street PDR S&P Retail ETF is trading nearer its 52-week high, GSK plc nearer its low. Which is the better fit depends on your goals.
| GSK | XRT | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $61.18 | $90.88 |
52-Week Low | $36.20 | $77.28 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
XRT (SPDR S&P Retail ETF) trades at $91.06, up 3.77% with strong bullish technical signals from moving averages. The ETF provides diversified exposure to US retail stocks amid mixed consumer sentiment. Recent retail sales data shows resilience with four consecutive months of growth, though consumer sentiment remains near record lows. Technical indicators show the ETF is approaching resistance levels with RSI in neutral territory.
The retail sector faces headwinds from inflation and negative real wage growth, but bargain-focused retailers show strength. Analyst sentiment is divided with some downgrades citing technical patterns and macroeconomic pressures. The ETF's broad diversification offers exposure to retail's digital transformation while navigating current consumer spending shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
